WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsSomalogic Inc (SLGC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 3431% more annual revenue ($2.89B vs $81.72M). MMED leads profitability with a -7.3% profit margin vs -159.5%. MMED earns a higher WallStSmart Score of 37/100 (F).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 5.0Value: 5.0Quality: 5.0

SLGC

Avoid

29

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED1 strengths · Avg: 10.0/10
Operating MarginProfitability
136.0%10/10

Strong operational efficiency at 136.0%

SLGC0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

MMED4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-7.3%1/10

Currently unprofitable

SLGC4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$396.23M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-23.7%2/10

ROE of -23.7% — below average capital efficiency

Revenue GrowthGrowth
-47.1%2/10

Revenue declined 47.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

The strongest argument for MMED centers on Operating Margin. Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : SLGC

SLGC has a balanced fundamental profile.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Free Cash Flow.

Bear Case : SLGC

The primary concerns for SLGC are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MMED is growing revenue faster at 13.1% — sustainability is the question.

MMED generates stronger free cash flow (-53M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 29/100) and 13.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Somalogic Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

None

Want to dig deeper into these stocks?